Weight loss options include lifestyle changes, GLP-1 drugs and surgery
People lose weight via three primary methods: diet and exercise, weight loss surgery and GLP-1 weight loss drugs. The ...
Health Rounds: Fewer post-surgery complications found in diabetes patients taking GLP-1 drugs
Hello, Health Rounds Readers! Today we feature a study that found yet another potential health benefit of GLP-1 drugs, this ...
Gala GLP1: The App Revolutionizing GLP-1 Treatment Management
With its innovative features and the upcoming launch of a direct medication purchasing service, Gala is set to become the ...
Why GLP-1 Drugs Are Real Threat To McDonald's Golden Arches
McDonald's shares underperformed in 2024, likely due to the rise of GLP-1 medications. Learn why MCD stock is a Sell.
Healio9h
GLP-1 receptor agonists tied to similar thyroid cancer risk as DPP-IV inhibitors
Adults with type 2 diabetes using a GLP-1 receptor agonist have a similar risk for developing thyroid cancer as those using a ...
manilatimes23h
Noom's GLP-1 Companion Receives Major Update to Prepare for New Expected Prescription Drug Use-Related Software (PDURS) Model
Noom releases a significant update of its innovative GLP-1 companion to improve medication persistence and adherence while ...
Hosted on MSN16h
Perioperative GLP-1 RA Use Reduces Risk for Complications in Patients With Diabetes
For patients with diabetes undergoing a surgical procedure, an active perioperative glucagon-like peptide-1 receptor agonist ...
GlobalData on MSN9h
Hengrui and Kailera report best-in-class data from Phase II GLP-1/GIP trial
Data from Hengrui’s Phase II trial for its GLP-1/GIP product demonstrated a statistically significant mean weight loss of ...
DarioHealth Expands GLP-1 Weight-Loss Solution, Unlocking New Revenue Streams in Rapidly Growing Multi Billion Dollar Market
Market News Alerts Updates that DarioHealth Corp. (Nasdaq: DRIO) is taking another bold step into the rapidly growing weight-loss market, now projected to exceed $100 billion annually by 2030. The ...
FiercePharma2h
JPM25: Eli Lilly's preliminary '24 sales figures show a continued easing in breakneck GLP-1 market
Unfortunately for the company, however, the early glimpse at its fourth-quarter performance doesn’t seem to be going over ...
LifeVantage: Bold Move Into The GLP-1 Weight Loss Market Turns Out To Be A Major Winner - Buy
LifeVantage's new MindBody GLP-1 System is riding the coattails of GLP-1 weight loss drugs. See why I rate LFVN stock as a ...
FoodBusinessNews23h
Reduced spending by GLP-1 users hits frozen category hardest
CHICAGO — The growing number of US consumers using GLP-1 drugs for weight loss are impacting specific sectors of the consumer ...